CLICK ABOVE to BUY TICKETS and/or DONATE
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is the largest charitable supporter of T1D research. The goal of JDRF is to improve the lives of every person affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing the disease. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970, JDRF has awarded more than $1.6 billion to T1D research, including $116 million in FY2011. More than 80 percent of JDRF’s expenditures directly support research and research-related education. Past JDRF research efforts have helped to significantly improve the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered.
Research funded by JDRF has led to many landmark advances in type 1 diabetes science. We aggressively translate discoveries into treatments, drugs, and therapies that help people with T1D live healthier lives now, while we work toward a cure. Currently, JDRF is funding more than 53 human clinical trials, several of which are in the advanced stages of clinical testing needed before FDA approvals are required.
JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia, and clinicians to ensure that JDRF and its partners are aligned and working toward a common goal of curing, treating, and preventing T1D.
JDRF was created-and is still led-by people with a personal connection to type 1 diabetes. Today, volunteers at JDRF’s more than 100 locations worldwide remain the driving force behind our activities. That gives us an unrelenting passion and commitment to find a cure – and, in the near term, better treatments – for people with T1D.
All of JDRF’s activities are driven by the needs of people with T1D. Whether it’s providing funding for a late-stage clinical trial, lobbying the government for faster approval of new devices, or partnering with a company on research that might not otherwise receive funding, every decision JDRF makes is driven by our commitment to transforming the lives of people with T1D-and delivering a cure-as soon as possible.
For more information, go to www.jdrf.org
2014 Mustache Bash :-{D 